It was reported that the procedure was to treat a mildly calcified, mildly tortuous, 100% stenosed lesion in the superficial femoral artery (sfa).A 5.5x200mm supera self-expanding stent system (sess) was advanced to the target lesion, the deployment lock was opened, and deployment was initiated, however, when the delivery system was withdrawn from the anatomy, the stent did not detach from the delivery system and the stent was removed from the anatomy.Another supera stent was used to successfully complete the procedure.There were no reported adverse patient effects and no clinically significant delays in the procedure.No additional information was provided.
|
The device was returned for analysis.The reported activation failure was able to be confirmed.The reported mechanical jam was unable to be replicated in a testing environment due to the condition of the returned device.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure.It is likely that the distal sheath of the delivery system was entrapped or bent in the mildly calcified, mildly tortuous and 100% stenosed anatomy such that the ratchet was unable to properly/fully engage the stent, resulting in difficulty advancing the thumbslide/ mechanical jam and the reported deployment difficulty/activation failure.Manipulation of the device resulted in the noted kinked sheath likely contributing to the reported difficulties.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|